Oncology Information System Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR (2024 - 2029) | 8.50 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Oncology Information System Market Analysis
The Oncology Information System Market is expected to register a CAGR of 8.5% during the forecast period.
The major factors attributing to the growth of the oncology information systems market include the rising incidence of cancer cases worldwide. For instance, according to a report published by Breast Cancer UK in May 2024, in 2022, female breast cancer accounted for 11.6% of all cancer diagnoses, positioning it as the second most prevalent cancer globally. In 2022, approximately 2.3 million women received a breast cancer diagnosis. Additionally, there were 8.2 million individuals living who had been diagnosed with breast cancer in the previous five years. The huge prevalence of cancer cases around the world is likely to increase the utilization of oncology information systems to handle large volumes of patient data. Thus, the market studied is expected to grow significantly over the forecast period.
Furthermore, growing initiatives to increase cancer awareness are expected to support market expansion over the forecast period. For instance, in February 2023, the World Health Organization unveiled its new Global Breast Cancer Initiative Framework, outlining a strategic plan to achieve the goal of saving 2.5 million lives from breast cancer by 2040. The initiative was released in anticipation of World Cancer Day, and the framework advises countries to adopt three foundational strategies: health promotion for early detection, ensuring timely diagnosis, and implementing comprehensive management of breast cancer. This initiative aims to guide nations in effectively meeting these targets through coordinated efforts in healthcare systems worldwide.
Moreover, in August 2022, the Koita Centre for Digital Oncology (KCDO) was founded by the National Cancer Grid (NCG) to encourage the use of digital technology and tools to enhance cancer care throughout India. The Koita Foundation had made contributions to the center's establishment, and it had committed to doing so for the next five years. At the Tata Memorial Hospital in Mumbai, the Tata Memorial Centre and Koita Foundation signed an MoU to formally establish their partnership. Such initiatives were expected to add to the growth of the market and improve cancer care in India.
The KCDO aimed to provide a platform for collaboration and knowledge-sharing among healthcare professionals, researchers, and innovators in the field of oncology. The center had also planned to develop and implement digital solutions to improve cancer screening, diagnosis, and treatment outcomes.
Thus, all the aforementioned factors, such as the growing prevalence of cancer and the rising adoption of OIS systems, are expected to propel the growth of the market. However, the high costs involved in cancer therapies and the dearth of skilled professionals are expected to slow down the market's growth over the forecast period.
Oncology Information System Market Trends
Software Segment is Expected to Hold the Largest Market Share in the Oncology Information System Market
The software segment has dominated the market owing to the increase in cancer patients globally and the tests associated with the examination and treatment of cancer patients. Software is a set of instructions, data, or programs used to operate computers and execute specific tasks. The use of software systems in cancer management can aid in controlling the rising oncology care costs and improving the efficiency of oncology care services by reducing medical errors, which is expected to significantly benefit the market.
Oncology information system (OIS) is a software solution that manages departmental, administrative, and clinical activities. It aggregates information into a complete oncology-specific electronic medical record to support medical information management. Thus, due to the benefits associated with oncology information software, the demand for it is expected to increase over the forecast period.
According to the REDECAN study published in November 2022, breast cancer was the most frequent cancer and the primary cause of cancer-related death in women in Spain, with an estimated 34,750 women diagnosed with the disease in Spain in 2022. Additionally, there were expected to be 30,948 new cases of lung cancer diagnosed in Spain in 2022.
Further, the same source mentioned above reported that in 2022, 22,316 men and 8,632 women were diagnosed with lung cancer. Thus, the growing prevalence of cancer and the need for early diagnostics are expected to increase, supporting segment expansion over the forecast period. The high number of people in the population affected by cancer results in an increasing demand for cancer management systems, which is expected to boost growth over the forecast period.
Product launches by key market players are also helping to drive the growth of the market studied. For instance, in June 2022, Roche launched its BenchMark ULTRA PLUS system, an advanced tissue staining platform. The system enables quick and accurate test results so clinicians can make timely decisions regarding a patient’s care journey. The rise in interest in the digitization of oncology services is expected to contribute to market growth over the forecast period.
Thus, the increased use of software in the management of cancer is expected to propel the growth of the segment over the forecast period.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall oncology information system market throughout the forecast period. This is owing to factors such as the rising prevalence of cancer and the availability of advanced healthcare infrastructure among the major factors.
For instance, according to a report published by the National Cancer Institute in May 2024, approximately 2.0 million individuals in the United States are projected to receive a cancer diagnosis. Breast cancer will be the most prevalent form, expected to affect 310,720 women and 2,790 men. Prostate cancer ranks as the primary diagnosis among men and second overall, with an estimated 299,010 cases anticipated. Lung and bronchus cancer follows as the third most frequently diagnosed cancer, with approximately 234,580 new cases expected.
Furthermore, according to a report published by the PubMed Journal in May 2024, the number of new cancer cases is expected to reach 247,100. Hence, the prevalence of cancer in the country is anticipated to create more opportunities for the development of oncology information systems by supporting the process of data integration in different phases, such as screening, prevention, diagnosis, and treatment. This is likely to boost the growth of the market.
Furthermore, an increase in awareness initiatives for cancer is expected to propel the growth of the market. For instance, every year in September, Cancer Awareness Month is observed in the United States. During National Breast Cancer Awareness Month, the government renewed its commitment to assisting patients and their families, increasing access to care, and raising awareness about the life-saving value of early detection. Such initiatives may increase awareness of the ailment and support market expansion over the forecast period.
Additionally, various organic and inorganic strategies adopted by the market players are expected to boost the market over the forecast period. For instance, in May 2022, GE Healthcare entered into an agreement with RaySearch Laboratories AB, a radiation oncology software provider, to develop a new radiation therapy simulation and treatment planning workflow solution designed to simplify how radiation will be targeted to shrink a tumor.
Thus, all aforementioned factors, such as the growing burden of cancer and government initiatives with product launches, are expected to boost market growth in the North American region over the forecast period.
Oncology Information System Industry Overview
The oncology information system market is moderately competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some prominent players are vigorously making acquisitions and joint ventures with other companies to consolidate their market positions across the globe. The major players are Cerner Corporation, Elekta AB, CureMD Corporation, McKesson Corporation, and Varian Medical Systems.
Oncology Information System Market Leaders
-
Oracle Corporation
-
Siemens Healthineers AG (Varian Medical Systems)
-
Elekta AB
-
Koninklijke Philips N.V.
-
McKesson Corporation
*Disclaimer: Major Players sorted in no particular order
Oncology Information System Market News
- May 2024: RaySearch Laboratories AB launched its oncology information system RayCare 2024A, which had been certified to be interoperable with Varian TrueBeam linear accelerators, version 3.0.
- February 2024: Hologic Inc. received clearance from the US Food and Drug Administration (FDA) for its new Genius Digital Diagnostics System with the Genius Cervical AI algorithm, which combines deep-learning-based artificial intelligence (AI) with advanced volumetric imaging technology to help identify pre-cancerous lesions and cervical cancer cells.
Oncology Information System Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumption and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising Incidence of Cancer Worldwide
- 4.2.2 Growing Government Initiatives for Cancer Awareness
-
4.3 Market Restraints
- 4.3.1 High Cost of Cancer Therapies
- 4.3.2 Dearth of Skilled Professionals
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - in USD)
-
5.1 By Product and Service
- 5.1.1 Software
- 5.1.2 Service
-
5.2 By Application
- 5.2.1 Medical Oncology
- 5.2.2 Radiation Oncology
- 5.2.3 Surgical Oncology
-
5.3 By End User
- 5.3.1 Hospitals
- 5.3.2 Research Centers
- 5.3.3 Specialty Clinics
-
5.4 By Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Oracle Corporation (Cerner Corporation)
- 6.1.2 Siemens Healthineers AG (Varian Medical Systems)
- 6.1.3 Elekta AB
- 6.1.4 Koninklijke Philips NV
- 6.1.5 McKesson Corporation
- 6.1.6 F. Hoffmann-La Roche Ltd (Flatiron Health Inc.)
- 6.1.7 Accuray Incorporated
- 6.1.8 RaySearch Laboratories AB
- 6.1.9 Optum Inc.
- 6.1.10 EndoSoft LLC
- 6.1.11 MIM Software Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityOncology Information System Industry Segmentation
As per the scope of the report, the oncology information system is used for data management as part of hospital oncology care plans, treatment plans, provision of medication, analysis, and treatment outcomes. Oncology information systems include the exchange of information between both the radiotherapy unit and the healthcare organization.
The oncology information system market is segmented by product and service, application, end user, and geography. The product and services segment is further segmented into software and services. The application segment is further divided into medical oncology, radiation oncology, and surgical oncology. The end user segment is further bifurcated into hospitals, research centers, and specialty clinics. The geography segment is further divided into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers the value (USD) for the above segments.
| By Product and Service | Software | |
| Service | ||
| By Application | Medical Oncology | |
| Radiation Oncology | ||
| Surgical Oncology | ||
| By End User | Hospitals | |
| Research Centers | ||
| Specialty Clinics | ||
| By Geography | North America | United States |
| Canada | ||
| Mexico | ||
| By Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| By Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| By Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| By Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Oncology Information System Market Research FAQs
What is the current Oncology Information System Market size?
The Oncology Information System Market is projected to register a CAGR of 8.5% during the forecast period (2024-2029)
Who are the key players in Oncology Information System Market?
Oracle Corporation, Siemens Healthineers AG (Varian Medical Systems), Elekta AB, Koninklijke Philips N.V. and McKesson Corporation are the major companies operating in the Oncology Information System Market.
Which is the fastest growing region in Oncology Information System Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Oncology Information System Market?
In 2024, the North America accounts for the largest market share in Oncology Information System Market.
What years does this Oncology Information System Market cover?
The report covers the Oncology Information System Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Oncology Information System Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Oncology Information Systems Industry Report
Statistics for the 2024 Oncology Information Systems market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Oncology Information Systems analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
